Where does Avectas Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Avectas Limited ranks #25,819 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Avectas Limited hold?

Avectas Limited holds 10 US utility patents granted between 2020 and 2025, spanning 11 technology areas.

What is Avectas Limited's Innovation Score?

Avectas Limited has an Innovation Score of 55.0 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Avectas Limited's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Avectas Limited.

What does claim depth mean for Avectas Limited's patents?

Avectas Limited's patents average 32.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Avectas Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Avectas Limited

Q: What technology areas does Avectas Limited focus on?

Avectas Limited's top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 9 patents, ranking #1,126 of 4,144 assignees active in that subclass. Grants appear in 11 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 11 technology areas, recorded in grant years 2020–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Avectas ranks #25,819 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 11 technology areas.

#25,819
of 49,997 US assignees by volume: Top 7%
by Innovation Score (55.0/100): 32.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R25819 · Foreign Corporation #25,819 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 10 grants
MID-PACK #25,819/49,997
PHOTO-FINISH Autonics
CPC-FOCUS C12N · 11 areas
INNOV-PAR 55.0/100
CLAIMS-DENSE 32.3 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2020–2025 · 6y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Autonics Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Avectas’s 55.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (15%) Velocity 20.0 pts (36%) Breadth 11.7 pts (21%) Claim depth 15.0 pts (27%)

Qualcomm Incorporated · highest

85
Avectas · this assignee

55
3D Lighting… · lowest

7

What this shows Avectas's Innovation Score is 55.0/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Avectas?

Each dot is one of Avectas’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Avectas’s own 32.3 claims/patent is ABOVE the 11.8 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Avectas vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Avectas's grants concentrate

Avectas Limited is a focused PatentsView assignee: 11 CPC subclasses with 90% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2024 (3 grants) versus a trough of 1 in 2020. By volume, Avectas sits between Autonics Corporation and Axcient, Inc..

Avectas's three-year grant acceleration

Avectas Limited shows 7 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Autonics

10
Auxocell Laborato…

10
Avant Medical

10
Avanzato Technolo…

10
Aventail

10
Avidbots

10
Avixgen

10
Axcient

10
Avectas ◀

10

What this shows Avectas holds 10 patents at rank #25,729, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Avectas

By rank, the assignees closest to #25,729 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Avectas's primary technology class.

Avectas's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

55 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2020–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.

View data table

Avectas Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2020	1	10.0%
2022	2	20.0%
2023	2	20.0%
2024	3	30.0%
2025partial year	2	20.0%

Which technologies does Avectas Limited patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

B05B - Spraying APPARATUS; Atomising APPARATUS; Nozzles 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 4

C07K - Peptides 2

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 2

B01D - Separation 2

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 11 of 11 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Avectas Limited's patent record in context - here's where to go next.

Avectas Limited's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 90% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #25,819 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Avectas Limited against Autonics Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 55.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.